Integrated Research Biotech Model (IRBM) is a CDMO/CRO committed to accelerating discovery and preclinical development of drug candidates such as small molecules and complex peptides. IRBM provides integrated scientific support and know-how for the development of drug discovery projects and compounds through its in-house HTS and NMR units, skilled medicinal chemistry and peptide chemistry groups, the very experienced ADME / DMPK group, CADD, in vitro biology, a proprietary phage library, and an in-house cGMP CMO facility currently focused on experimental adenoviral vaccine production. The services include preclinical research, pharmacology and biochemistry, particularly in the fields of Infectious Diseases, Neurodegeneration, and Oncology.